WRF Capital — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
Arzeda designs proteins and metabolic pathways using computational tools, including its Archytas protein design software and Scylax metabolic pathway design software.
AI & Machine LearningBiotechDeep TechFoodTechNew MaterialsSeattle, US
Alexandre Zanghellini(Co-Founder & Chief Executive Officer)inEric Althoff(Executive Officer, Director, Promoter)inDavid Baker(Co-founder and Scientific Advisor)Bill Baum(Director)inAndrew Ban(Executive Officer)Daniela Grabs(Executive Officer)
Co-investorsCirculate CapitalFall Line CapitalSofinnova PartnersSustainable Conversion VenturesContinental Grain CompanyLewis & Clark AgriFood+2 more
AgTechPullman, US
Amit Dhingra(Executive Officer, Director)Chris Leyerle(Executive Officer, Director)
BoardJack Snyder(Director)
Co-investorsKeiretsu Forum
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








